FRANKLIN COVEY CO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data FRANKLIN COVEY CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	200	185	210	225	198	224	263	281	287	267
Cost of revenue	64.9	62.6	61.5	66	53.1	51.3	60.9	67	66.2	63.5
Gross profit	135	123	148	159	145	173	202	213	221	204
Selling, general and administrative	114	121	138	141	130	154	168	178	176	183
Operating income	13.8	-8.88	-3.37	2.66	3.06	8.1	23.7	26.4	33	5.7
Interest expense	2.26	2.41	2.68	2.36	2.32	2.1	1.68	1.58	1.12	0.57
Interest income	0.12	0.22	0.1	0.04	0.06	0.07	0.07	1.09	1.12	0.93
Pre-tax income	11.9	-10.9	-5.52	0.59	0.8	6.08	22.1	25.9	33	6.07
Income tax	4.9	-3.74	0.37	1.62	10.2	-7.55	3.63	8.09	9.64	3
Net income	7.02	-7.17	-5.89	-1.02	-9.44	13.6	18.4	17.8	23.4	3.07
EBITDA	20.8	-1.44	7.16	14	14.3	14.3	28.6	30.6	36.9	9.77
EPS, basic	0.47	-0.52	-0.43	-0.07	-0.68	0.97	1.30	1.30	1.78	0.24
EPS, diluted	0.47	-0.52	-0.43	-0.07	-0.68	0.96	1.27	1.24	1.74	0.24
Shares, basic (weighted)	14.9	13.8	13.8	13.9	13.9	14.1	14.1	13.6	13.2	12.9
Shares, diluted (weighted)	15.1	13.8	13.8	13.9	13.9	14.1	14.6	14.3	13.5	13.1

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	10.5	8.92	10.2	27.7	27.1	47.4	60.5	38.2	48.7	31.7
Receivables	66	66.3	71.9	73.2	56.4	70.7	72.6	81.9	86	68.4
Inventory	5.04	3.16	3.16	3.48	2.97	2.5	3.53	4.21	4	5.17
Other current assets	3.4	9.39	10.9	11	11.5	12.9	14.6	16.2	16.5	19.1
Total current assets	89.7	91.8	100	119	102	137	156	145	160	129
Property, plant and equipment	16.1	19.7	21.4	18.6	15.7	11.5	9.8	10	8.74	14.3
Lease right-of-use assets				1.6	1.2	1.78	1.11	0.81	1.14	6.93
Goodwill	19.9	24.2	24.2	24.2	24.2	31.2	31.2	31.2	31.2	31.2
Intangible assets	50.2	57.3	51.9	47.7	47.1	50.1	44.8	40.5	37.8	34.6
Other non-current assets	13.7	16	12.9	10	15.6	15.2	12.7	17.5	22.7	33.1
Total assets	191	211	214	225	205	250	259	246	262	243
Accounts payable	10.4	9.12	9.79	9.67	5.62	6.95	10.9	6.5	7.86	8.78
Accrued liabilities	17.4	22.6	20.8	23.6	22.6	35	34.2	28.3	32.5	24.8
Deferred revenue	20.8	40.8	47.4	56.3	59.3	74.8	85.5	95.4	101	107
Short-term debt	1.66	1.87	2.09
Total current liabilities	54.1	80.6	94.8	104	103	137	154	152	162	157
Long-term debt						13	7.27	1.54	0.78
Lease liabilities					0.51	1.14	0.52	0.23	0.63	6.34
Other non-current liabilities	3.17	5.74	5.5	7.53	9.11	8.74	7.12	7.62	10.7	14.7
Total liabilities	97.2	126	133	143	146	170	176	167	178	176
Total debt	1.66	1.87	2.09			18.8
Paid-in capital	211	212	211	216	212	215	220	232	232	230
Retained earnings	76.6	69.5	63.6	59.4	50	63.6	82	99.8	123	126
Treasury stock	-197	-199	-196	-195	-204	-201	-220	-254	-272	-290
Other comprehensive income	1.22	0.67	0.34	0.27	0.64	0.71	-0.54	-0.99	-0.77	-1.03
Shareholders' equity	93.7	85.1	80.5	82	59.5	79.9	82.8	78.7	83.1	66.9
Total equity	93.7	85.1	80.5	82	59.5	79.9	82.8	78.7	83.1	66.9
Total liabilities and equity	191	211	214	225	205	250	259	246	262	243

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	7.02	-7.17	-5.89	-1.02	-9.44	13.6	18.4	17.8	23.4	3.07
Depreciation and amortization	6.94	7.44	10.5	11.4	11.3	6.19	4.9	4.27	3.91	4.07
Stock-based compensation	3.12	3.66	2.85	4.79	-0.57	8.62	8.29	12.5	10.1	5.81
Deferred income tax	1.77	-6.06	-2.34	-1.05	8.98	-9.61	0.21	4.91	1.76	1.06
Change in receivables	-0.58	0.16	-5.68	-1.77	17.1	-14.3	-2.41	-9.45	-3.76	17.5
Change in inventory	-0.91	1.58	0.16	-0.26	0.55	0.46	-1.05	-0.69	0.23	-1.16
Change in payables	2.26	0.68	1.75	2.93	-5.46	14.4	4.36	-9.54	0.4	-5.77
Cash from operations	32.7	17.4	16.9	30.5	27.6	46.2	52.3	35.7	60.3	29
Capital expenditures	-3.99	-7.19	-6.53	-4.15	-4.18	-1.6	-3.18	-4.52	-3.69	-8.25
Acquisitions		-7.27	-1.11	-0.03		-10.2
Cash from investing	-6.23	-21.7	-10.6	-6.87	-11.9	-14.3	-5.33	-13.6	-11.3	-16.9
Debt repaid	-1.47	-1.66	-1.87	-2.09	-2.34	-2.6	-2.89	-3.2	-3.54	-3.11
Share buybacks	-43.6	-5.43	-2.01	-0.01	-14	-2.97	-23.9	-35.6	-30.7	-26.4
Cash from financing	-32.5	3.13	-4.68	-5.93	-16.6	-11.5	-32.7	-44.2	-38.7	-28.8
Exchange rate effect	0.32	-0.35	-0.32	-0.1	0.3	-0.1
Net change in cash	-5.78	-1.53	1.23	17.5	-0.56	20.3	13.1	-22.3	10.4	-17
Free cash flow	28.7	10.2	10.3	26.3	23.4	44.6	49.1	31.2	56.6	20.7
Interest paid	2.23	2.31	2.66	2.39	2.28	2.07	1.66	1.5	1.11	0.5
Income taxes paid	3.41	2.56	2.51	1.78	2.06	1.77	3.21	3.31	4.21	7.69

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to May 31, 2026; growth uses fiscal years. Valuation uses the share price of $17.31 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	75.2%	Gross profit / revenue.
Operating margin	2.4%	Operating income / revenue.
EBITDA margin	4.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	2.4%	Pre-tax income / revenue.
Net margin	0.8%	Net income / revenue.
FCF margin	7.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	10.4%	Cash from operations / revenue.
Effective tax rate	66.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	5.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	1.1%	Net income / average total assets.
Return on invested capital (ROIC)	16.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	67.4%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	2.2%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.1%	Capital expenditures / revenue.
D&A / revenue	1.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-7.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	0.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.1%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-7.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	0.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	7.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-82.7%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-37.8%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	13.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-73.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-30.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-7.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-86.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-45.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	-86.2%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-42.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-51.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-17.8%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	1.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-63.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-25.0%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-2.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-19.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-6.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	2.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-7.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-2.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	3.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-3.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-3.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.66x	Current assets / current liabilities.
Quick ratio	0.44x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.09x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	78.3%	Total liabilities / total assets.
Interest coverage	19.1x	Operating income / interest expense.
Working capital	-$48.3M	Current assets - current liabilities.
Goodwill and intangibles / assets	31.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$20.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.33x	Revenue / average total assets.
Fixed asset turnover	20.9x	Revenue / average property, plant and equipment.
Inventory turnover	11.2x	Cost of revenue / average inventory.
Days inventory	32 days	365 x average inventory / cost of revenue.
Receivables turnover	5.23x	Revenue / average receivables.
Days sales outstanding	70 days	365 x average receivables / revenue.
Days payables	36 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	66 days	Days inventory + days sales outstanding - days payables.
FCF conversion	882.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	29.6%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.19	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$22.95	Revenue / diluted weighted shares.
FCF per share	$1.68	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.39	Cash from operations / diluted weighted shares.
Book value per share	$3.75	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$1.76	Tangible book value / shares outstanding.
Cash per share	$1.05	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	163.3%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$195.5M	Share price x shares outstanding.
Enterprise value	$183.5M	Market cap + total debt - cash - short-term investments.
P/E	89.4x	Market cap / net income. Only when net income is positive.
P/S	0.74x	Market cap / revenue.
P/B	4.55x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	10.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	7.13x	Market cap / cash from operations, when positive.
EV/Sales	0.70x	Enterprise value / revenue.
EV/EBIT	28.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	16.8x	Enterprise value / EBITDA, when both are positive.
EV/FCF	9.51x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.9%	Free cash flow / market cap.
Earnings yield	1.1%	Net income / market cap (the inverse of P/E).
Shareholder yield	16.1%	(Dividends paid + share buybacks) / market cap.

What was FRANKLIN COVEY CO's revenue in fiscal 2025?

FRANKLIN COVEY CO reported revenue of $267.1M for fiscal 2025, 7% lower than the year before.

Was FRANKLIN COVEY CO profitable in fiscal 2025?

Yes. Net income was $3.1M, a net margin of 1.1%.

How much free cash flow did FRANKLIN COVEY CO generate in fiscal 2025?

Cash from operations of $29.0M minus capital expenditures of $8.3M left free cash flow of $20.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to FRANKLIN COVEY CO